Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study

View Full Paper

Ask AI

Bookmark

Triple therapy adherence and persistence patterns reflect real-world utilization among patients with COPD, with treatment continuity depending heavily on ongoing therapy regimens.
Analysis of German claims data examines patient adherence and long-term persistence to triple therapy, focusing on long-acting muscarinic antagonist regimens within routine care.
Understanding adherence and persistence to triple therapy among patients with COPD highlights critical gaps in long-term disease management, calling for improved patient support.

No abstract yet

We only have this paper's title and publication details.

Claims data study observes adherence and persistence to triple therapy in patients with COPD, highlighting real-world treatment duration.

Triple therapy (long-acting muscarinic antagonist/long-acting β

No takes yet. Share an insight, caveat, or question.

Vogelmeier et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark

Claims data study observes adherence and persistence to triple therapy in patients with COPD, highlighting real-world treatment duration.

Triple therapy (long-acting muscarinic antagonist/long-acting β